Unlock all Features See Plans and Pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Express Scripts
Boehringer Ingelheim
AstraZeneca
Dow
Merck

Last Updated: August 17, 2022

Investigational Drug Information for Daprodustat


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions


What is the development status for investigational drug Daprodustat?

Daprodustat is an investigational drug.

There have been 13 clinical trials for Daprodustat. The most recent clinical trial was a Phase 3 trial, which was initiated on November 21st 2016.

The most common disease conditions in clinical trials are Renal Insufficiency, Chronic, Anemia, and Kidney Diseases. The leading clinical trial sponsors are GlaxoSmithKline, Quintiles, Q2 Solutions, HemoCue, ERT, and ERT: Clinical Trial Technology Solutions.

There are nine US patents protecting this investigational drug and one hundred and twenty-three international patents.

Recent Clinical Trials for Daprodustat
TitleSponsorPhase
Comparison of Daprodustat Formulations Produced by Two Methods of Manufacture for Bioequivalence and Dissolution in Healthy ParticipantsGlaxoSmithKlinePhase 1
Anemia Studies in CKD: Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor (PHI) Daprodustat- Iron (ASCEND: Fe)GlaxoSmithKlinePhase 2
Anemia Study in Chronic Kidney Disease (CKD) : Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor (PHI) Daprodustat -Forearm Blood Flow (ASCEND-FBF)GlaxoSmithKlinePhase 2

See all Daprodustat clinical trials

Clinical Trial Summary for Daprodustat

Top disease conditions for Daprodustat
Top clinical trial sponsors for Daprodustat

See all Daprodustat clinical trials

US Patents for Daprodustat

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Daprodustat See Plans and Pricing Controlled release dosage form TRIASTEK, INC. (Nanjing, CN) See Plans and Pricing
Daprodustat See Plans and Pricing Bicyclic-fused heteroaryl or aryl compounds as IRAK4 modulators Pfizer Inc. (New York, NY) See Plans and Pricing
Daprodustat See Plans and Pricing Oral drug dosage forms having desired drug release profiles and uses thereof Triastek, Inc. (Nanjing, CN) See Plans and Pricing
Daprodustat See Plans and Pricing Bicyclic-fused heteroaryl or aryl compounds as IRAK4 modulators Pfizer Inc. (New York, NY) See Plans and Pricing
Daprodustat See Plans and Pricing Bicyclic-fused heteroaryl or aryl compounds Pfizer Inc. (New York, NY) See Plans and Pricing
Daprodustat See Plans and Pricing Compartmented pharmaceutical dosage forms Triastek, Inc. (Nanjing, CN) See Plans and Pricing
Daprodustat See Plans and Pricing Bicyclic-fused heteroaryl or aryl compounds Pfizer Inc. (New York, NY) See Plans and Pricing
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for Daprodustat

Drugname Country Document Number Estimated Expiration Related US Patent
Daprodustat Australia AU2017261372 2036-05-05 See Plans and Pricing
Daprodustat Canada CA3023278 2036-05-05 See Plans and Pricing
Daprodustat China CN107847398 2036-05-05 See Plans and Pricing
Daprodustat European Patent Office EP3452003 2036-05-05 See Plans and Pricing
Daprodustat European Patent Office EP3981392 2036-05-05 See Plans and Pricing
Daprodustat Hong Kong HK1249728 2036-05-05 See Plans and Pricing
Daprodustat Japan JP2019520866 2036-05-05 See Plans and Pricing
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Express Scripts
Boehringer Ingelheim
AstraZeneca
Dow
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.